183 related articles for article (PubMed ID: 36801152)
21. New approaches to lymphoma diagnosis.
Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
[TBL] [Abstract][Full Text] [Related]
22. [Morphology, immunohistochemistry and genetics of peripheral T cell lymphomas].
Lennert K; Feller AC; Gödde-Salz E
Onkologie; 1986 Apr; 9(2):97-107. PubMed ID: 3520428
[TBL] [Abstract][Full Text] [Related]
23. [2016 revision of the WHO classification of lymphoid neoplasms].
Tamaru JI
Rinsho Ketsueki; 2017; 58(10):2188-2193. PubMed ID: 28978864
[TBL] [Abstract][Full Text] [Related]
24. Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
Satou A; Bennani NN; Feldman AL
Expert Rev Hematol; 2019 Oct; 12(10):833-843. PubMed ID: 31365276
[No Abstract] [Full Text] [Related]
25. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gaillard JB; Chapiro E; Daudignon A; Nadal N; Penther D; Chauzeix J; Nguyen-Khac F; Veronese L; Lefebvre C
Curr Res Transl Med; 2023; 71(4):103428. PubMed ID: 38016421
[TBL] [Abstract][Full Text] [Related]
26. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
Burg G; Kempf W; Cozzio A; Feit J; Willemze R; S Jaffe E; Dummer R; Berti E; Cerroni L; Chimenti S; Diaz-Perez JL; Grange F; Harris NL; Kazakov DV; Kerl H; Kurrer M; Knobler R; Meijer CJ; Pimpinelli N; Ralfkiaer E; Russell-Jones R; Sander C; Santucci M; Sterry W; Swerdlow SH; Vermeer MH; Wechsler J; Whittaker S
J Cutan Pathol; 2005 Nov; 32(10):647-74. PubMed ID: 16293178
[TBL] [Abstract][Full Text] [Related]
27. [WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors].
Baram DV; Asaulenko ZP; Spiridonov IN; Krivolapov YA
Arkh Patol; 2023; 85(4):24-31. PubMed ID: 37530187
[TBL] [Abstract][Full Text] [Related]
28. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
Mathé G; Belpomme D; Dantchev D; Pouillart P
Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
[TBL] [Abstract][Full Text] [Related]
29. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
30. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
31. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
32. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
33. Detection of B- and T-cells in paraffin-embedded tissue sections. Diagnostic utility of commercially obtained 4KB5 and UCHL-1.
Clark JR; Williams ME; Swerdlow SH
Am J Clin Pathol; 1990 Jan; 93(1):58-69. PubMed ID: 2403743
[TBL] [Abstract][Full Text] [Related]
34. [Immunopathology of lymphatic systemic diseases].
Huber H; Gattringer C
Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
[TBL] [Abstract][Full Text] [Related]
35. Effect of haematological malignancies and their treatment on host defence factors.
Hersh EV; Gutterman JU; Mavligit GM
Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
[TBL] [Abstract][Full Text] [Related]
36. What's new in lymphoma cytogenetics?
Kristoffersson U
Pathol Res Pract; 1988 Feb; 183(1):100-6. PubMed ID: 3362747
[TBL] [Abstract][Full Text] [Related]
37. Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up.
Vega F; Amador C; Chadburn A; Hsi ED; Slack G; Medeiros LJ; Feldman AL
Mod Pathol; 2022 Mar; 35(3):306-318. PubMed ID: 34584212
[TBL] [Abstract][Full Text] [Related]
38. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
[TBL] [Abstract][Full Text] [Related]
39. [Grayzone lymphoma. Clinical relevance].
Hartmann S; Hansmann ML
Pathologe; 2010 Feb; 31(1):42-9. PubMed ID: 20013122
[TBL] [Abstract][Full Text] [Related]
40. Leu-M1 antigen expression in acute leukaemias.
de Mascarel A; Coindre JM; de Mascarel I; David B; Trojani M; Broustet A
J Pathol; 1987 Nov; 153(3):225-32. PubMed ID: 3501459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
